Study finds persistent racial disparities and growing sex disparities of bariatric patients
There are persistent racial disparities and growing sex disparities between patients who discussed and received bariatric and metabolic...
top of page
Headlines
Researcher 2 Researcher and Bariatric News - The Podcasts
Spend an engaging hour with Researcher 2 Researcher and Bariatric News as we explore a range of topics in Bariatric and Metabolic...
Research
Micronutrient deficiencies are common in people with type 2 diabetes
Micronutrient deficiencies are common in people with type 2 diabetes, according to the findings of a pooled data analysis of the...
TNF Pharmaceuticals initiates study evaluating TNF-alpha inhibitor isomyosamine in preserving lean muscle mass after GLP-1
TNF Pharmaceuticals has initiated the first in a series of studies to evaluate the impact of its novel oral TNF-alpha (TNF-α) inhibitor...
Napo Pharmaceuticals files patent application for crofelemer to mitigate GLP-1 side-effects
Napo Pharmaceuticals has filed a broad defining provisional patent application with the US Patent and Trademark Office (USPTO) for...
RYGB and SG lower health care costs for T2DM patients
In patients with type 2 diabetes, Roux-en-Y gastric bypass and sleeve gastrectomy for weight loss may be effective for reducing long-term...
FDA approves semaglutide to reduce the risk of worsening kidney disease and cardiovascular death
The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to...
Journal Watch 29/1/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
SPECCIAL study: BMS significantly lowers future progression of cirrhosis
Patients with obesity and fatty liver-related cirrhosis who had bariatric surgery significantly lowered their future risk of developing...
CMS approves new quality measure tied to GLP-1 use and pulmonary aspiration
The Centers for Medicare & Medicaid Services (CMS) formally approved a new quality measure developed by the Quality Team at North...
Novo Nordisk completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
Novo Nordisk has announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor...
No haemodynamic and respiratory differences between reverse Trendelenburg and beach chair positions during LSG
There was no difference between reverse Trendelenburg position (RTP) and beach chair (BC) position during laparoscopic sleeve...
SGLT-2 dapagliflozin plus moderate calorie restriction achieves higher diabetes remission than calorie restriction alone
Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug...
Allurion plans study to optimise muscle mass during GLP-1 therapy in combination with the Allurion Program
Allurion Technologies plans to initiate a clinical study on the combination of the Allurion Program with GLP-1 agonists to improve muscle...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
Tweets
bottom of page